# Characterization of Anti-HLA Alloimmunization After Pulmonary Valve Homograft Insertion

> **NCT06113224** · NA · NOT_YET_RECRUITING · sponsor: **Assistance Publique Hopitaux De Marseille** · enrollment: 53 (estimated)

## Conditions studied

- Lung Graft Dysfunction

## Interventions

- **PROCEDURE:** Blood collection T0
- **PROCEDURE:** Blood collection 6 months

## Key facts

- **NCT ID:** NCT06113224
- **Lead sponsor:** Assistance Publique Hopitaux De Marseille
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2023-12
- **Primary completion:** 2026-06
- **Final completion:** 2027-06
- **Target enrollment:** 53 (ESTIMATED)
- **Last updated:** 2023-11-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06113224

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06113224, "Characterization of Anti-HLA Alloimmunization After Pulmonary Valve Homograft Insertion". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06113224. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
